[Tacrolimus (FK506): clinical, pharmacological and analytical aspects].
Brunet
M
M
Servicio de Toxicología, Hospital Clínic i Provincial, Universidad de Barcelona.
D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D004347:Drug Interactions; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D016030:Kidney Transplantation; D016031:Liver Transplantation; D015337:Multicenter Studies as Topic; D016559:Tacrolimus / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016559:Tacrolimus